$1,318.00
This Market Spotlight report covers the Polycystic Ovary Syndrome (PCOS) market, comprising key marketed and pipeline drugs, clinical trials, probability of success, and a 10-year disease prevalence forecast, as well as licensing and acquisition deals.
This Market Spotlight report covers the Polycystic Ovary Syndrome (PCOS) market, comprising key marketed and pipeline drugs, clinical trials, probability of success, and a 10-year disease prevalence forecast.
Key Takeaways
CONTENTS
5 OVERVIEW
6 KEY TAKEAWAYS
7 DISEASE BACKGROUND
8 TREATMENT
8 Clomiphene citrate
8 Gonadotropins
8 Antidiabetic agents
8 Aromatase inhibitors
8 Anti-androgens
9 Oral contraceptive pills
10 EPIDEMIOLOGY
15 MARKETED DRUGS
17 PIPELINE DRUGS
21 PROBABILITY OF SUCCESS
22 CLINICAL TRIAL LANDSCAPE
23 Sponsors by status
24 Sponsors by phase
26 BIBLIOGRAPHY
27 APPENDIX
LIST OF FIGURES
12 Figure 1: Trends in prevalent cases of PCOS (Rotterdam Criteria), 2019–28
14 Figure 2: Trends in prevalent cases of PCOS (NIH Criteria), 2019–28
17 Figure 3: Overview of pipeline drugs for PCOS in the US
17 Figure 4: Pipeline drugs for PCOS, by company
17 Figure 5: Pipeline drugs for PCOS, by drug type
18 Figure 6: Pipeline drugs for PCOS, by classification
21 Figure 7: Probability of success in the endocrine-other pipeline
22 Figure 8: Clinical trials in PCOS
22 Figure 9: Top 10 drugs for clinical trials in PCOS
23 Figure 10: Top 10 companies for clinical trials in PCOS
23 Figure 11: Trial locations in PCOS
24 Figure 12: PCOS trials status
25 Figure 13: PCOS trials sponsors, by phase
LIST OF TABLES
11 Table 1: Prevalent cases of PCOS (Rotterdam Criteria), 2019–28
13 Table 2: Prevalent cases of PCOS (NIH Criteria), 2019–28
16 Table 3: Marketed drugs for PCOS
19 Table 4: Pipeline drugs for PCOS in the US
© Pharma Intelligence UK Ltd. This document is a licensed product and is not to be reproduced or redistributed
Do you have a subscription to Datamonitor Healthcare, Biomedtracker or Meddevicetracker? You may already have access to these reports, contact your account manager or email pharma@informabi.com for further help or assistance.
Sign up to the Pharma Intelligence Report Store Newsletter to get the latest blogs, news, reports and discounts!